PDHB
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial
Also known as: E1beta, ODPB_HUMAN, PDHE1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11177
- Gene
- PDHB
- Ensembl
- ENSG00000168291
- Chromosome
- 3
- Canonical length
- 359 aa
- Protein class
- Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and carbon dioxide, and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 beta subunit. Mutations in this gene are associated with pyruvate dehydrogenase E1-beta deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>P11177|PDHB
1 MAAVSGLVRR PLREVSGLLK RRFHWTAPAA LQVTVRDAIN QGMDEELERD EKVFLLGEEV
61 AQYDGAYKVS RGLWKKYGDK RIIDTPISEM GFAGIAVGAA MAGLRPICEF MTFNFSMQAI
121 DQVINSAAKT YYMSGGLQPV PIVFRGPNGA SAGVAAQHSQ CFAAWYGHCP GLKVVSPWNS
181 EDAKGLIKSA IRDNNPVVVL ENELMYGVPF EFPPEAQSKD FLIPIGKAKI ERQGTHITVV
241 SHSRPVGHCL EAAAVLSKEG VECEVINMRT IRPMDMETIE ASVMKTNHLV TVEGGWPQFG
301 VGAEICARIM EGPAFNFLDA PAVRVTGADV PMPYAKILED NSIPQVKDII FAIKKTLNILocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDHB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 279 nTPM
Expression across tissuesHPA
Tissue
- tongue: 279 nTPM
- skeletal muscle: 255 nTPM
- heart muscle: 164 nTPM
- choroid plexus: 125 nTPM
- liver: 104 nTPM
- kidney: 94 nTPM
Single-cell type
- cytotrophoblasts: 205 nCPM
- syncytiotrophoblasts: 176 nCPM
- esophageal suprabasal cells: 167 nCPM
- migrating cytotrophoblasts: 166 nCPM
- parietal cells: 164 nCPM
- esophageal apical cells: 153 nCPM
Immune cell
- myeloid DC: 141 nTPM
- NK-cell: 130 nTPM
- total PBMC: 124 nTPM
- intermediate monocyte: 115 nTPM
- T-reg: 114 nTPM
- non-classical monocyte: 110 nTPM
Brain region
- choroid plexus: 62 nTPM
- white matter: 41 nTPM
- cerebellum: 40 nTPM
- thalamus: 38 nTPM
- hypothalamus: 37 nTPM
- cerebral cortex: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDHB.
Disease | AllUniProt
Conditions PDHB is implicated in, by any mechanism.
- Pyruvate dehydrogenase E1-beta deficiency (PDHBD) MIM:614111
Disease | GeneticClinVar
44 pathogenic / likely-pathogenic of 444 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pyruvate dehydrogenase E1-beta deficiency
- Pyruvate dehydrogenase phosphatase deficiency
- Thyroid cancer, nonmedullary, 1
- Uterine corpus endometrial carcinoma
- Acute myeloid leukemia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.15
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transketolase-like, pyrimidine-binding domain
- Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II
- Thiamin diphosphate-binding fold
- Transketolase, C-terminal domain
- Transketolase, pyrimidine binding domain
- Transketolase, C-terminal domain
- Pyruvate dehydrogenase E1 component subunit beta, mitochondrial-type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDHB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDHB as an antibody target. Whether an autoantibody or antibody against PDHB could matter depends on whether native PDHB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDHB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDHB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...